- Home
- SOS vs ADVB Comparison
SOS vs ADVB Comparison
Compare SOS & ADVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOS
- ADVB
- Stock Information
- Founded
- SOS 2004
- ADVB 2014
- Country
- SOS China
- ADVB United States
- Employees
- SOS N/A
- ADVB N/A
- Industry
- SOS Finance: Consumer Services
- ADVB Medical Specialities
- Sector
- SOS Finance
- ADVB Health Care
- Exchange
- SOS Nasdaq
- ADVB Nasdaq
- Market Cap
- SOS 10.7M
- ADVB 9.7M
- IPO Year
- SOS 2017
- ADVB 2025
- Fundamental
- Price
- SOS $1.21
- ADVB $0.42
- Analyst Decision
- SOS
- ADVB
- Analyst Count
- SOS 0
- ADVB 0
- Target Price
- SOS N/A
- ADVB N/A
- AVG Volume (30 Days)
- SOS 44.4K
- ADVB 1.7M
- Earning Date
- SOS 09-26-2025
- ADVB 11-19-2025
- Dividend Yield
- SOS N/A
- ADVB N/A
- EPS Growth
- SOS N/A
- ADVB N/A
- EPS
- SOS N/A
- ADVB N/A
- Revenue
- SOS $260,505,000.00
- ADVB N/A
- Revenue This Year
- SOS N/A
- ADVB N/A
- Revenue Next Year
- SOS N/A
- ADVB N/A
- P/E Ratio
- SOS N/A
- ADVB N/A
- Revenue Growth
- SOS 134.43
- ADVB N/A
- 52 Week Low
- SOS $1.02
- ADVB $0.34
- 52 Week High
- SOS $15.51
- ADVB $4.10
- Technical
- Relative Strength Index (RSI)
- SOS 34.62
- ADVB 49.56
- Support Level
- SOS $1.11
- ADVB $0.36
- Resistance Level
- SOS $1.40
- ADVB $0.43
- Average True Range (ATR)
- SOS 0.15
- ADVB 0.04
- MACD
- SOS -0.02
- ADVB -0.00
- Stochastic Oscillator
- SOS 21.76
- ADVB 53.46
About SOS SOS Limited
SOS Ltd is a multifaceted company that leverages the power of data to provide marketing solutions, while also participating in the burgeoning fields of blockchain and cryptocurrency operations, as well as commodity trading. Its product offerings are diversified across four main areas: commodity trading, insurance marketing, cryptocurrency mining, and other services. The company has three reporting segments: Commodity trading, Cryptocurrency mining, and Others. Key revenue is generated from Commodity trading.
About ADVB Advanced Biomed Inc. Common Stock
Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.